BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29480593)

  • 21. Recurrence of adenomatoid odontogenic tumor.
    Ide F; Matsumoto N; Miyazaki Y; Kikuchi K; Kusama K
    J Oral Pathol Med; 2019 Jan; 48(1):96-97. PubMed ID: 30403429
    [No Abstract]   [Full Text] [Related]  

  • 22. Conservative treatment of an aggressive odontogenic tumor: a case report.
    Catunda IS; Vasconcelos BC; Macedo Neres BJ; de Araujo RA; Ponzi EA
    Gen Dent; 2013; 61(6):e8-12. PubMed ID: 24064176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiologic and histologic aspects of 100 cases of ameloblastoma of the jaws].
    Bazzucchi M; Camussi E; Diani GM; Frattegiani T; Guerra M
    Dent Cadmos; 1987 Feb; 55(3):73-80. PubMed ID: 3477493
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral pathology quiz #43. Case number 2. Ameloblastoma.
    J N J Dent Assoc; 2004; 75(2):22, 42. PubMed ID: 16795957
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anatomo-clinical and radiological aspects of ameloblastomas].
    Cunha AS; da Costa HF; Portugal C; Miranda A
    Rev Port Estomatol Cir Maxilofac; 1980; 23(3):327-40. PubMed ID: 7348338
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation.
    Fernandes GS; Girardi DM; Bernardes JPG; Fonseca FP; Fregnani ER
    BMC Cancer; 2018 Sep; 18(1):887. PubMed ID: 30208863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.
    Kondo S; Ota A; Ono T; Karnan S; Wahiduzzaman M; Hyodo T; Lutfur Rahman M; Ito K; Furuhashi A; Hayashi T; Konishi H; Tsuzuki S; Hosokawa Y; Kazaoka Y
    Cancer Med; 2020 Apr; 9(8):2904-2917. PubMed ID: 32096304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma.
    Liu X; Chen Z; Lan T; Liang P; Tao Q
    Int J Mol Med; 2019 Jun; 43(6):2329-2340. PubMed ID: 31017256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of ameloblastoma based on pathologic and anatomic principles.
    Gardner DG; Pecak AM
    Cancer; 1980 Dec; 46(11):2514-9. PubMed ID: 7438024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Roentgenologic analysis of 183 cases of odontogenic tumors of the jaws].
    Wu YT
    Zhonghua Fang She Xue Za Zhi; 1983 May; 17(2):114-9. PubMed ID: 6226502
    [No Abstract]   [Full Text] [Related]  

  • 31. Ameloblastoma revisited.
    Jones RH
    Ann R Australas Coll Dent Surg; 1996 Apr; 13():174-80. PubMed ID: 9178993
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell proliferation and chromosomal changes in human ameloblastoma.
    Jääskeläinen K; Jee KJ; Leivo I; Saloniemi I; Knuutila S; Heikinheimo K
    Cancer Genet Cytogenet; 2002 Jul; 136(1):31-7. PubMed ID: 12165448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of the roentgeno-pathology of ameloblastoma of the jaw].
    Ning SC
    Zhonghua Kou Qiang Ke Za Zhi; 1984 Jun; 19(2):72-5. PubMed ID: 6596178
    [No Abstract]   [Full Text] [Related]  

  • 34. [Research advances in the v-raf murine sarcoma viral oncogene homolog gene mutation in ameloblastoma].
    Yan XC; Sun LS; Dong ZW; You Z; Dong Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jul; 53(7):500-502. PubMed ID: 29996373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity of the PTCH gene in ameloblastoma.
    Farias LC; Gomes CC; Brito JA; Galvão CF; Diniz MG; de Castro WH; Bernardes Vde F; De Marco LA; Gomez RS
    Hum Pathol; 2012 Aug; 43(8):1229-33. PubMed ID: 22221699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
    Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
    Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review.
    You Z; Liu SP; Du J; Wu YH; Zhang SZ
    J Oral Pathol Med; 2019 Mar; 48(3):201-205. PubMed ID: 30489659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic expression profiling of six odontogenic tumors.
    Carinci F; Francioso F; Piattelli A; Rubini C; Fioroni M; Evangelisti R; Arcelli D; Tosi L; Pezzetti F; Carinci P; Volinia S
    J Dent Res; 2003 Jul; 82(7):551-7. PubMed ID: 12821718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Well differentiated metastasizing ameloblastoma--report of a case with review of literature.
    Pradhan SA; Soman CS; Patel A
    Indian J Cancer; 1989 Dec; 26(4):255-9. PubMed ID: 2699878
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinicopathological characteristics of desmoplastic ameloblastoma: A systematic review.
    Anand R; Sarode GS; Sarode SC; Reddy M; Unadkat HV; Mushtaq S; Deshmukh R; Choudhary S; Gupta N; Ganjre AP; Patil S
    J Investig Clin Dent; 2018 Feb; 9(1):. PubMed ID: 28707772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.